Coffee and liver health: Exploring the protective benefits and mechanisms of coffee and its bioactive compounds in liver disorders
Abstract
Coffee, one of the most widely consumed beverages worldwide, has garnered significant attention for its health benefits. Beyond its stimulant effects, studies highlight its potential role in reducing the risk of liver diseases such as non-alcoholic fatty liver disease (NAFLD), cirrhosis, and hepatocellular carcinoma (HCC). This editorial explores the mechanisms underlying these protective effects, emphasizing the interplay between bioactive compounds in coffee and liver health. By integrating epidemiological, clinical, and biochemical insights, this article also explores how moderate coffee consumption can contribute to liver disease prevention and public health strategies.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
